Janssen bags new EU approval for Darzalex by Selina McKee | Sep 3, 2018 | News | 0 Janssen’s Darzalex has been approved in Europe for the first-line treatment of patients with multiple myeloma. Read More
Darzalex combo wins nod for newly diagnosed multiple myeloma by Selina McKee | May 8, 2018 | News | 0 Janssen’s Darzalex has become the first monoclonal antibody to be approved in the US to treat patients newly diagnosed with multiple myeloma. Read More
J&J’s Darzalex shows promise in newly-diagnosed multiple myeloma by Selina McKee | Dec 13, 2017 | News | 0 Johnson & Johnson group Janssen has unveiled new data showing a 50 percent cut in the risk of disease progression or death in patients with newly diagnosed multiple myeloma given Darzalex on top of standard treatment. Read More